Allstate Rating Increased to Overweight at Barclays Capital (ALL)

By admin | 6 years ago

Allstate (NYSE: ALL) was upgraded by analysts at Barclays Capital (NYSE: BCS) from an “equal weight” rating to an “overweight” rating in a research report issued to clients and investors on Friday. The firm currently has a $39.00 price target on the stock, up from their previous price target of $38.00.

A number of other firms have also recently commented on ALL. Analysts at Zacks reiterated a “neutral” rating on shares of Allstate in a research note to investors on Thursday. They now have a $35.00 price target on the stock. Separately, analysts at UBS AG (NYSE: UBS) reiterated a “buy” rating on shares of Allstate in a research note to investors on Thursday. Finally, analysts at Goldman Sachs (NYSE: GS) upgraded shares of Allstate from a “sell” rating to a “neutral” rating in a research note to investors on Thursday.

Allstate traded up 0.18% on Friday, hitting $34.26. Allstate has a 52-week low of $22.27 and a 52-week high of $34.40. The company has a market cap of $16.834 billion and a price-to-earnings ratio of 17.03.

Allstate last posted its quarterly earnings results on Wednesday, May 2nd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.43. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. Analysts expect that Allstate will post $0.75 EPS next quarter.

The Allstate Corporation (Allstate), incorporated on November 5, 1992, is a holding company of Allstate Insurance Company.

About the author